COVID-19 Updates

The Institute can help screen, identify and safely treat any potential cases of COVID-19.

Newly Diagnosed

The compassionate team of experts at the Institute is here to help you every step of the way after a cancer diagnosis.

Refer a Patient

If you're a physician with a patient you'd like us to help care for, we're ready to collaborate with you.

More than 30 oncology physicians and a full complement of oncology professionals are on staff to serve the patients at the Lynn Cancer Institute. Our patients receive treatment and services from specialists in genetics, surgery, radiation oncology, medical oncology, pathology and imaging. In addition, our staff includes research nurses, who improve patient access to clinical trials and the most advanced forms of treatment.

A unique approach at the Lynn Cancer Institute is our multimodality care. Each multimodality team is comprised of physicians and healthcare professionals who specialize in a specific site of cancer. The team is able to develop standards of care for the specific disease site it treats. These standards reflect the most advanced technology and current treatments available.

This simplifies the entire process for our patients, from diagnosis and treatment, to Wellness and Survivorship programs and allows our patients to focus on one thing — recovery.

Our Approach

Our renowned cancer professionals work together across multiple specialties to provide you with advanced cancer screenings, diagnostics and personalized care.

The Advantage of Multimodality Care

The Advantage of Multimodality Care

At the Institute, we understand the importance of great care. Our multimodal approach to care brings together a team of physicians and healthcare professionals who specialize in a specific site of cancer. We are ready to care for you.

Zdenka Ena Segota, M.D.

Hematologist Oncologist
Zdenka Ena Segota, M.D.

Physician Spotlight

Zdenka Ena Segota, M.D., is a board-certified hematologist oncologist. Her clinical interests include breast cancer and hematologic malignancies such as lymphoma and myeloma.

Dr. Segota has extensive research experience, putting her at the forefront of innovations in cancer care. During her career, she has served as principal investigator or sub-investigator on numerous clinical trials that have resulted in the development of many new oncology medications. These studies aim to improve patients’ pre-surgical and post-surgical outcomes as well as metastatic cancer survival rates.

Dr. Segota enjoys connecting and interacting with her patients and believes that every person deserves to receive an individual approach to cancer care. She offers patients precision medicine through genomic testing. This type of testing identifies disease-associated variants to help match patients to more personalized therapies or assess a patient’s disease risk and help target more effective therapies.

Recent News

Have questions?

We're here to help answer any questions you or your family may have.

Language Preference / Preferencia de idioma

I want to see the site in English

Continue In English

Quiero ver el sitio en Español

Continuar en español